Database Query Results : , , TREM-1

TREM-1, triggering receptor expressed on myeloid cells-1: Click to Expand ⟱
Source:
Type:
TREM1 promotes tumor progression, immunosuppression, and resistance to therapy by activating tumor-infiltrating myeloid cells.
sTREM-1 Serum soluble triggering receptor expressed on myeloid cells-1.
High levels of sTREM-1 were observed in 50% of breast cancer, 33.3% of Small Cell Lung carcinoma (SCLC), 26.7% of colorectal cancer and 13.3% of Non Small Cell Lung Carcinoma (NSCLC) patients.
Scientific Papers found: Click to Expand⟱
190- MFrot,  MF,    The efficacy and safety of low-frequency rotating static magnetic field therapy combined with chemotherapy on advanced lung cancer patients: a randomized, double-blinded, controlled clinical trial
- Human, Lung, NA
*IP-10/CXCL-10↑, *GM-CSF↑, *TREM-1↓,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Transcription & Epigenetics ⓘ

TREM-1↓, 1,  

Immune & Inflammatory Signaling ⓘ

GM-CSF↑, 1,   IP-10/CXCL-10↑, 1,  
Total Targets: 3

Scientific Paper Hit Count for: TREM-1, triggering receptor expressed on myeloid cells-1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:536  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page